Axel Bolte - Sep 30, 2022 Form 4 Insider Report for Inozyme Pharma, Inc. (INZY)

Role
Chief Executive Officer, Director
Signature
/s/ Axel Bolte
Stock symbol
INZY
Transactions as of
Sep 30, 2022
Transactions value $
$7,558
Form type
4
Date filed
10/4/2022, 08:00 AM
Previous filing
May 13, 2022
Next filing
Apr 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INZY Common Stock Award $7.56K +3.32K +1.28% $2.28 262K Sep 30, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased pursuant to the Inozyme Pharma, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of April 1, 2022 through September 30, 2022. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the issuer's common stock on September 30, 2022.